Rezultaty - Yuanyuan Xie
- Rezultaty 1 - 3 Rezultaty od 3
-
1
Clinical characteristics of bronchopulmonary dysplasia and the risk of sepsis onset prediction via machine learning models od Yanhua Wang, Yanhua Wang, Yanhua Wang, Yanhua Wang, Yi Wang, Yi Wang, Yi Wang, Linhong Song, Jun Li, Jun Li, Jun Li, Yuanyuan Xie, Yuanyuan Xie, Yuanyuan Xie, Lei Yan, Lei Yan, Lei Yan, Siqi Hu, Siqi Hu, Siqi Hu, Zhichun Feng, Zhichun Feng, Zhichun Feng, Zhichun Feng
Wydane 2025-06-01Bronchopulmonary dysplasia (BPD), also known as chronic lung disease, is the most common cause of respiratory morbidity in preterm infants. Sepsis plays a significant role in the pathogenesis of BPD, and the systemic inflammatory response caused by sepsis is associated with lung development, leading...
Dokumenty pełnotekstowe
Artykuł -
2
Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity od Meiqi Yi, Jian Sun, Hanzi Sun, Yifei Wang, Shan Hou, Beibei Jiang, Yuanyuan Xie, Ruyue Ji, Liu Xue, Xiao Ding, Xiaomin Song, April Xu, Chichi Huang, Quan Quan, Jing Song
Wydane 2023-12-01Aspartic acid (Asp) isomerization is a spontaneous non-enzymatic post-translation modification causing a change in the structure of the protein backbone, which is commonly observed in therapeutic antibodies during manufacturing and storage. The Asps in Asp–Gly (DG), Asp–Ser (DS), and Asp–Thr (DT) mo...
Dokumenty pełnotekstowe
Artykuł -
3
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies od Yuqi Wang, Quan Quan, Camille Gleason, Helin Yu, Lujia Peng, Yanshen Kang, Ling Jiang, Kailun Wu, Jie Pan, Moxiyele Bao, Qing Zhu, Meiqi Yi, Ming Fang, Yue Zheng, Ling Qiu, Bin Xu, Xiang Li, Jinfeng Song, Jiamu Sun, Zheng Zhang, Zijun Su, Jara Lin, Yuanyuan Xie, April Xu, Xiling Song, Chichi Huang, Zhirong Shen, Lai Wang, Jing Song
Wydane 2023-12-01Pharmaceutical companies have recently focused on accelerating the timeline for initiating first-in-human (FIH) trials to allow quick assessment of biologic drugs. For example, a stable cell pool can be used to produce materials for the toxicology (Tox) study, reducing time to the clinic by 4–5 mont...
Dokumenty pełnotekstowe
Artykuł